R

REGENXBIO
D

RGNX

7.85000
USD
0.29
(3.77%)
مغلق
حجم التداول
35,235
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
388,928,807
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    1.73
    (0.65%)
    266.69 USD
    B
    BLUE
    -0.31000
    (-3.79%)
    7.86000 USD
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    E
    EDIT
    0.15000
    (12.50%)
    1.35000 USD
    N
    NTLA
    1.040
    (10.45%)
    10.990 USD
    Q
    QURE
    0.390
    (2.61%)
    15.310 USD
    R
    RARE
    1.650
    (4.00%)
    42.950 USD
    S
    SGMO
    0.03500
    (3.13%)
    1.15500 USD
    S
    SRPT
    -0.920
    (-0.79%)
    116.020 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    المزيد
الأخبار
المقالات

العنوان: REGENXBIO

القطاع: Healthcare
الصناعة: Biotechnology
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.